v3.25.4
INCOME TAXES - Additional Information (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Taxes [Line Items]      
Foreign income $ 304,852 $ 194,551 $ 16,794
Provision (benefit) for income taxes 9,405 (99,218) 6,725
Foreign deferred benefit 2,198 106,762 713
State current provision 1,934 1,600 4,022
Foreign current provision 9,669 5,944 3,416
Increase (decrease) in valuation allowance $ (56,600) (28,500) 623,000
Percentage of taxable income available to be offset 80.00%    
Unrecognized tax benefits $ 77,969 59,371 $ 0
Unrecognized tax benefits, additions based on tax positions related to current period 10,460 5,080  
Unrecognized tax benefits related to prior year positions 9,467 54,291  
Settlements 1,329 0  
Change In Accounting Method      
Income Taxes [Line Items]      
Increase (decrease) in valuation allowance (71,400)    
Additional Tax Attributes Generated      
Income Taxes [Line Items]      
Increase (decrease) in valuation allowance 14,800    
Foreign Tax Jurisdiction      
Income Taxes [Line Items]      
Provision (benefit) for income taxes   $ (108,000)  
Net operating loss carryforward 731,800    
Federal      
Income Taxes [Line Items]      
Net operating loss carryforward 3,230,000    
Net operating loss carryforwards, subject to expiration 873,000    
Net operating loss carryforwards, not subject to expiration 2,360,000    
Federal | Research and Development, Including Orphan Drug, and State Investments Tax Credit      
Income Taxes [Line Items]      
Tax credit carryforwards 411,700    
State and local jurisdiction      
Income Taxes [Line Items]      
Net operating loss carryforward 3,700,000    
State and local jurisdiction | Research and Development, Including Orphan Drug, and State Investments Tax Credit      
Income Taxes [Line Items]      
Tax credit carryforwards $ 51,400